Skip to main content
ACS Omega logoLink to ACS Omega
. 2024 Jun 5;9(24):26275–26284. doi: 10.1021/acsomega.4c02105

Decarboxylative Aldol Reaction of α,α-Difluoro-β-keto Esters: Easy Access to Difluoroenolate

Atsushi Tarui 1, Hiroshi Shimomura 1, Yohei Yasuno 1, Yukiko Karuo 1, Kazuyuki Sato 1, Kentaro Kawai 1, Masaaki Omote 1,*
PMCID: PMC11190933  PMID: 38911753

Abstract

graphic file with name ao4c02105_0009.jpg

Yb(OTf)3 promoted the Krapcho decarboxylation of 2,2-difluoro-3-oxopropanoate, and a subsequent aldol reaction was achieved. This process is the first example of generating difluoroenolates through a decarboxylation-type process, and a large number of carbonyl compounds are applicable to the aldol reaction. The protocol is a complete one-pot reaction that uses the bench-stable and nonhygroscopic 2,2-difluoro-3-oxopropanoate to generate the difluoroenolate. This strategy has been applied for the synthesis of CF2-containing bioactive GABAB agonists, contributing to drug design.

Introduction

Fluorine-containing compounds play an important role in medicine, as they can contribute to increased lipophilicity, metabolic stability, and improved solubility.1 In particular, the difluoromethylene unit has unique properties; it is considered a bioisostere of an oxygen atom and carbonyl group and can modify the pKa value of neighboring atoms.2 The synthesis of α,α-difluoro-β-carbonyl compounds can be achieved via classical deoxyfluorination.3 However, the requirement for the use of a highly toxic fluorine reagent amino sulfur trifluoride ((diethylamino)sulfur trifluoride) poses a drawback for the deoxyfluorination of ketones. Difluoromethylated carbonyl compounds are also accessible through the decarboxylation of β-oxo-α,α-difluorocarboxylic acids and their salts (1, Figure 1A).4

Figure 1.

Figure 1

(A) Fluorine-containing decarboxylative substrates; (B) our reported decarboxylative aldol reaction of β-oxo-α,α-difluorocarboxylate potassium salt.

The synthesis of difluoromethylene compounds using decarboxylation has been expanded to include the introduction of an aryl group.5 In this study, the decarboxylation method was expanded to include a wide range of skeletal transformations. Decarboxylation reactions are environmentally friendly chemical transformations that only involve the release of CO2. Therefore, decarboxylative bond formation reactions of carboxylic acids have been utilized to introduce various substituents, including C–C bond formation.6 Among them, the decarboxylative aldol reaction of β-oxocarboxylic acids has been widely investigated as a C–C bond formation reaction, which affords the formal enolate equivalents by releasing CO2 from the carboxylic acids.7

We have also achieved the decarboxylative aldol reaction of 1b (Figure 1B). According to these investigations, the generation of enolates from readily decarboxylatable carboxylic acids and their salts has been established for both nonfluorine and fluorine analogs and applied to bond formation reactions.

In contrast to the broadly applicable decarboxylation chemistry of carboxylic acids, reactions using β-ketoesters as direct substrates for decarboxylation reactions are scarce except for Krapcho decarboxylation. The reaction has been used as a simple skeletal transformation,8 which is used to degrade ester moieties from the carbon skeleton.9 To the best of our knowledge, there is only one example of a bond formation reaction using Krapcho decarboxylation, in which CF3 anions generated from trifluoroacetates are used for cross-coupling.10 The most significant advantage of skeletal transformation reactions using β-ketoesters is that substituents can be introduced using the active methylene moiety, which is often used in combination with the Krapcho decarboxylation reaction for carbon chain elongation reactions by introducing substituents and removing unnecessary ester moieties (Scheme 1, eqs 1 and 2).11 Unfortunately, a similar bond formation with 2 in which the two active hydrogens are replaced by fluorine atoms has not been achieved (Scheme 1, eq 3). In this study, we investigated the aldol reaction of compound 2, which does not have an active methylene moiety, followed by the generation of a formal enolate from difluoro-β-ketoester directly. This offers a novel consecutive Krapcho-type decarboxylation/aldol reaction for the C–C bond formation (Scheme 1, eq 4). Indeed, the reaction of β-oxo-α,α-difluoropropanoate (2) with benzaldehyde, using metals and NaCl as additives, provided a direct aldol adduct via the enolate from 2. Herein, we describe the first example of a decarboxylative aldol reaction of β-oxo-α,α-difluoropropanoate (2) using Yb(OTf)3 to afford 2,2-difluoro-3-hydroxypropan-1-ones in excellent yields. The newly proposed difluoroenolate precursor 2, unlike the corresponding carboxylic acids and their salts, is an easy-to-handle, chromatographically purifiable, and long-storable reactant. Furthermore, the synthesis of 2 is one step less than the corresponding carboxylic acids and their salts, allowing easier access to the difluoroenolate precursor.

Scheme 1. Approaches for the Introduction of a Functional Group into the α-Position of β-Oxopropanoate Using Krapcho Decarboxylation: (1) Substituent Introduction Followed by Krapcho Decarboxylation for Nonfluorinated β-Oxopropanoate; (2) Substituent Introduction Followed by Krapcho Decarboxylation for Fluorinated β-Oxopropanoate; (3) Unsuccessful Similar Functionalization β-Oxo-α,α-Difluoropropanoate without Active Methylene; (4) This Study.

Scheme 1

Results and Discussion

We commenced our investigation using the conditions employed in our previous decarboxylative aldol reaction with potassium 2,2-difluoro-3-oxo-3-phenylpropanoate. The reaction of ethyl 2,2-difluoro-3-oxo-3-phenylpropanoate (2a) with benzaldehyde (3a) using NaCl as a trigger for Krapcho decarboxylation provided the aldol product 4aa in low yield (Table 1, entry 1). The reaction was performed in DMSO containing an equimolar ratio of both H2O and 2a, which is a commonly used condition in the Krapcho decarboxylation method. Next, the reaction solvents were screened (entries 2–7). As shown entries 2–4, polar solvents such as DMF, NMP, and DMA were not effective in this reaction, and the decarboxylated side product 5 was predominantly recovered. On the other hand, less polar solvents such as toluene and THF were not effective for this Krapcho decarboxylation, and the starting material 2a was recovered in moderate-to-high yields (entries 5 and 6). However, acetonitrile was found to be effective in both the decarboxylation and aldol processes, affording the desired product in moderate yield (entry 7). To improve the yield of product 4aa, further screening of the decarboxlative substrate 6a and Lewis acid was investigated (Table 2). A further increase in yield was observed when methyl ester 6a was used by shortening the carbon chain of the ester alkoxy moiety of substrate 2a for a more efficient Krapcho decarboxylation (entry 1). The most effective improvements resulted from screening for Lewis acids. Several Lewis acids did not provide the desired product 4aa (see the Supporting Information, Table S1).12 The most effective metal additive was Yb(OTf)3 hydrate, which afforded the product in 95% yield (entry 2). Finally, reagent-grade NaCl (99.5% purity) provided the optimal conditions for the quantitative yield of the product (entry 3). The reaction without Yb(OTf)3 hydrate did not afford the desired product, and the moderate yield of 6a was recovered from the reaction mixture (entry 4). This indicates that a metal additive is necessary for the Krapcho decarboxylation/aldol reaction. The amount of additive was investigated with the aim of a catalyst loading of Yb(OTf)3; however, a decrease in the yield of 4aa was observed.13

Table 1. Screening of Solvents Using α,α-Difluoro-β-ketoester 2a.

graphic file with name ao4c02105_0005.jpg

entry solvent temp. (°C) isolated yield of 4aa (%) 19F NMR yield of 2a (%) 19F NMR yield of 5 (%)
1 DMSO 150 20 0 34
2 DMF 150 13 0 50
3 NMP 150 25 0 40
4 DMA 150 0 0 51
5 toluene reflux 0 94 0
6 THF reflux 20 48 7
7 CH3CN reflux 42 35 0

Table 2. Investigation of Methylester 6a and Further Screening of Reaction Condition.

graphic file with name ao4c02105_0006.jpg

entry Lewis acid purity of NaCI (%) isolated yield of 4aa (%) 19F NMR yield of 6a (%) 19F NMR yield of 5 (%)
1 ZnCI2 TMEDA 95.0 55 16 16
2 Yb(OTf)3 nH2O 95.0 95 trace 0
3 Yb(OTf)3 nH2O 99.5 99 trace 0
4 none 99.5 0 50 18

Having established the optimal experimental conditions, the reactivities of various aldehydes were explored. As shown in Table 3a, this method was found to be applicable to a variety of aldehydes 3, which underwent this decarboxylative aldol reaction successfully, affording the corresponding products 4aa4ap in 10–99% yields. The substituents of electron effects and substitution positions on the aromatic ring gave products without affecting their yields. Products 4ao and 4ap from aliphatic aldehydes were also obtained in moderate yields of 44–62%. In the cases of 4ag, 4am, and 4ap, low conversion of 6a and aldehydes was observed. The reaction of 6a with ketones using an excess of an electrophile (1 mL) also provided the target product 4aq in 63% yield. Subsequently, we further explored the scope of α,α-difluoro-β-ketoesters 6b6f (Table 3b). Different substituents on the benzene ring had good compatibility and afforded the desired products 4ca4da in 75–95% yields. Substrates bearing aliphatic ketoesters 6e and 6f provided the corresponding products in moderate yields.

Table 3. Scope and Limitations of Substrates.

graphic file with name ao4c02105_0007.jpg

graphic file with name ao4c02105_0008.jpg

a

The reaction was stirred for 48h.

This reaction is also applicable to the synthesis of GABAB agonist 12. After synthesizing the corresponding α,α-difluoro-β-ketoester 11, the method was applied to 11, and the desired bioactive product 12 was successfully obtained (Scheme 2).

Scheme 2. Synthesis of Biological Active Compound toward GABAB Agonist 12.

Scheme 2

Several control experiments were performed to further investigate the reaction mechanism. The retro-aldol reaction of 4aa was investigated in the presence of Zn and Yb (Scheme 3a,b). In the presence of Yb(OTf)3, no retro-aldol process was observed with quantitative recovery of the substrate 4aa. However, the Zn metal condition provided the retro-aldol product 5 with reduced recovery of 4aa. The results suggest that Yb(OTf)3 is the most effective additive for controlling the retro-aldol reaction in this system. Furthermore, nonfluorinated β-ketoesters 13 and 15 were used in the Krapcho/aldol reaction (Scheme 3c,d). α,α-Dimethyl substituted β-ketoester 13 did not provide the corresponding product 14, and the Krapcho decarboxylation of 13 was not observed, with the recovery of 13 in 92% yield. Additionally, α-nonsubstituted β-ketoester 15 did not give rise to the corresponding product 16. However, the nondecarboxylation and condensation products 17 were obtained in low yields in this case. They may have been generated by the reaction between the active methylene moiety of 15 and benzaldehyde 3a. These results suggest that the difluoro substituents at the α-position are necessary and promote the Krapcho decarboxylation.

Scheme 3. Retro-Aldol Reactions and Control Experiments.

Scheme 3

Yields determined by 19F NMR using benzotrifluoride as an internal standard.

Conclusions

In conclusion, we succeeded in exploiting a novel and synthetically valuable method for the formation of C–CF2 bonds via a Krapcho decarboxylative/aldol reaction between various carbonyl compounds and methyl α,α-difluoro-β-propanoate in the presence of Yb(OTf)3. This transformation is the first that uses an α,α-difluoro-β-ketoester via Krapcho decarboxylation as the formal enolate equivalent, leading to C–C bond formation through the Krapcho/aldol consecutive reaction. The system was compatible with a wide range of methyl α,α-difluoro-β-propanoates, and a variety of carbonyl compounds bearing multifunctional groups were tolerated well. This methodology features a readily available β-ketoester and completely one-pot reaction. Furthermore, the developed method was applied to synthesize a CF2-containing GABAB agonist as an example of its utility for the preparation of bioactive compounds. This research provides a path to the β-keto difluoromethylene unit, which is a valuable intermediate in the synthesis of many fine chemicals and naturally occurring compounds. Investigations to clarify the reaction mechanism and reactions with other electrophiles are currently underway.

Experimental Section

General Information

All commercially available reagents were purchased as reagent grades and were used without further purification unless otherwise stated. Solvents were heated to reflux over Na metal with benzophenone ketyl (THF), P2O5 (CH2Cl2), and CaH2 (CH3CN and N-methyl-2-pyrrolidone (NMP)) under an argon atmosphere and collected by distillation just before use. Anhydrous N,N-dimethylacetamide (DMA) was purchased from wako chemicals. All reactions were carried out under an Ar atmosphere and monitored by thin-layer chromatography (TLC) unless otherwise stated. TLCs were performed on silica gel 60 F254 and visualized by exposure to UV light. Flash column chromatography was performed using SiliCycle silica gel (SiliaFlash, 230–400 mesh). Melting points of the products obtained were measured using cover glass and were not corrected. NMR spectra were recorded at 400 MHz for 1H, 100 MHz for 13C, and 376 Hz for 19F using CDCl3 as a solvent. Chemical shifts of 1H and 13C NMR are reported in ppm downfield of TMS (1H and 13C = 0.00 ppm) and CDCl3 (13C δ = 77.2 ppm). Chemical shifts of 19F NMR are reported in ppm from CFCl3 as an internal standard. 13C NMR spectra were obtained with 1H decoupling. All data are reported as follows: chemical shifts, multiplicity (standard abbreviations), coupling constants (Hz), and relative integration value. HRMS experiments were measured on a double-focusing mass spectrometer with an ionization mode of EI.

Synthesis of β-Hydroxy-α,α-difluoro Ester via Honda–Reformatsky Reaction14

A flame-dried reaction vessel was cooled to room temperature and filled with argon. To this flask were added RhCl(PPh3)3 (1 mol %), the corresponding aldehyde (1.0 equiv), methyl bromodifluoroacetate (18, 1.5 equiv), and CH3CN (8.0 mL/aldehyde). The reaction mixture was cooled at 0 °C with an ice bath. Finally, diethylzinc (1.5 equiv, 1.0 M in hexane) was added dropwise over a period of 20 min and the reaction mixture was stirred at room temperature. After the reaction was complete (monitored by TLC), the reaction mixture was quenched with 10% aqueous HCl and extracted with ethyl acetate. The extract was washed with brine and dried with MgSO4, and then the filtrate was collected and concentrated in vacuo. The residue was purified by column chromatography on silica gel (EtOAc/C6) to afford the desired product 19.

Methyl 2,2-Difluoro-3-hydroxy-3-phenylpropanoate (19a)15

Yield 91% (3.901 g), colorless liquid. 1H NMR (400 MHz, CDCl3) δ 7.45–7.39 (m, 5H), 5.18 (ddd, J = 15.7, 7.4, 5.2 Hz, 1H), 3.87 (s, 3H), 2.65 (brd, J = 5.2 Hz, 1H); 13C{1H} NMR (100 MHz, CDCl3) δ 164.0 (t, J = 32.3 Hz), 134.3, 129.4, 128.5, 127.7, 113.8 (dd, J = 259.6, 253.8 Hz), 73.8 (dd, J = 27.9, 24.1 Hz), 53.5; 19F NMR (376 MHz, CDCl3) δ −113.1 (dd, J = 263.4, 7.4 Hz, 1F), −120.8 (dd, J = 263.4, 15.7 Hz, 1F). MS m/z = 216 [M+]; HRMS (EI): m/z [M+] calcd for C10H10F2O3: 216.0598; found: 216.0597.

Methyl 2,2-Difluoro-3-hydroxy-3-(naphthalen-2-yl)propanoate (19b)15

This reaction was carried out using 3 equiv of 18 and diethyl zinc, respectively. Yield 72% (576.1 mg), colorless solid, mp 92.3–93.3 °C (from CHCl3–C6). 1H NMR (400 MHz, CDCl3) δ 7.91–7.84 (m, 4H), 7.55–7.50 (m, 3H), 5.34 (dd, J = 15.9, 7.5 Hz, 1H), 3.86 (s, 3H), 2.85 (brs, 1H); 13C{1H} NMR (100 MHz, CDCl3) δ 164.1 (dd, J = 32.8, 30.8 Hz), 133.7, 132.9, 131.7, 128.3, 128.2, 127.7, 127.5, 126.7, 126.5, 124.7, 113.9 (dd, J = 259.6, 253.8 Hz), 73.9 (dd, J = 28.4, 24.6 Hz), 53.6; 19F NMR (376 MHz, CDCl3) δ −112.7 (dd, J = 263.5, 7.5 Hz, 1F), −120.4 (dd, J = 263.5, 15.9 Hz, 1F). MS m/z = 266 [M+]; HRMS (EI): m/z [M+] calcd for C14H12F2O3: 266.0755; found: 266.0759.

Methyl 2,2-Difluoro-3-hydroxy-3-(4-methoxyphenyl)propanoate (19c)

This reaction was carried out by using 3 equiv of 18 and diethyl zinc, respectively. Yield 97% (718.4 mg), colorless solid, mp 68.0–69.0 °C (from CHCl3–C6). 1H NMR (400 MHz, CDCl3) δ 7.36 (d, J = 8.7 Hz, 2H), 6.92 (d, J = 8.7 Hz, 2H), 5.11 (ddd, J = 15.9, 7.9, 5.0 Hz, 1H), 3.86 (s, 3H), 3.82 (s, 3H), 2.63 (d, J = 5.0 Hz, 1H); 13C{1H} NMR (100 MHz, CDCl3) δ 164.1 (t, J = 31.8 Hz), 160.3, 129.0, 126.4, 113.9, 113.8 (dd, J = 261.9, 253.3 Hz), 73.4 (dd, J = 27.9, 24.1 Hz), 55.3, 53.5; 19F NMR (376 MHz, CDCl3) δ −113.5 (dd, J = 262.3, 7.9 Hz, 1F), −120.8 (dd, J = 262.3, 15.9 Hz, 1F). MS m/z = 246 [M+]; HRMS (EI): m/z [M+] calcd for C11H12F2O4: 246.0704; found: 246.0707.

Methyl 3-(4-Chlorophenyl)-2,2-difluoro-3-hydroxypropanoate (19d)16

Yield 82% (612.2 mg), colorless solid, mp 52.0–53.0 °C (from C6). 1H NMR (400 MHz, CDCl3) δ 7.39 (s, 4H), 5.17 (ddd, J = 15.7, 7.2, 5.1 Hz, 1H), 3.88 (s, 3H), 2.68 (d, J = 5.1 Hz, 1H); 13C{1H} NMR (100 MHz, CDCl3) δ 163.9 (t, J = 32.3 Hz), 135.3, 132.8, 129.0, 128.7, 113.5 (dd, J = 260.1, 253.3 Hz), 73.1 (dd, J = 27.9, 24.1 Hz), 53.6; 19F NMR (376 MHz, CDCl3) δ −112.7 (dd, J = 265.2, 7.2 Hz, 1F), −120.9 (dd, J = 265.2, 15.7 Hz, 1F). MS m/z = 250 [M+]; HRMS (EI): m/z [M+] calcd for C10H9ClF2O3: 250.0208; found: 250.0213 (100), 252.0181 (33).

Methyl 2,2-Difluoro-3-hydroxy-5-phenylpentanoate (19e)17

Yield 77% (562.1 mg), colorless liquid. 1H NMR (400 MHz, CDCl3) δ 7.32–7.29 (m, 2H), 7.23–7.20 (m, 3H), 4.08–3.97 (m, 1H), 3.89 (s, 3H), 2.93 (ddd, J = 13.9, 9.1, 5.1 Hz, 1H), 2.74 (ddd, J = 13.9, 8.6, 8.2 Hz, 1H), 2.10 (d, J = 6.9 Hz, 1H), 2.06–1.98 (m, 1H), 1.94–1.84 (m, 1H); 13C{1H} NMR (100 MHz, CDCl3) δ 164.0 (dd, J = 33.2, 31.3 Hz), 140.7, 128.6, 128.5, 126.3, 114.6 (dd, J = 257.2, 254.3 Hz), 71.0 (dd, J = 27.0, 25.0 Hz), 53.5, 31.2, 30.7 (m); 19F NMR (376 MHz, CDCl3) δ −114.2 (dd, J = 266.4, 7.6 Hz, 1F), −121.9 (dd, J = 266.4, 15.2 Hz, 1F). MS m/z = 244 [M+]; HRMS (EI): m/z [M+] calcd for C12H14F2O3: 244.0911; found: 244.0912.

Methyl 3-Cyclohexyl-2,2-difluoro-3-hydroxypropanoate (19f)

Yield 88% (1.327 g), colorless liquid. 1H NMR (400 MHz, CDCl3) δ 3.90 (s, 3H), 3.88–3.78 (m, 1H), 2.10 (d, J = 8.2 Hz, 1H), 1.93–1.90 (m, 1H), 1.81–1.65 (m, 5H), 1.32–1.08 (m, 5H); 13C{1H} NMR (100 MHz, CDCl3) δ 164.4 (dd, J = 32.8, 30.8 Hz), 115.5 (dd, J = 258.2, 255.3 Hz), 75.2 (dd, J = 26.5, 23.6 Hz) 53.4, 38.2, 29.6, 27.3, 26.1, 25.8; 19F NMR (376 MHz, CDCl3) δ −110.9 (dd, J = 264.1, 7.6 Hz, 1F), −120.2 (dd, J = 264.1, 18.4 Hz, 1F). MS m/z = 222 [M+]; HRMS (EI): m/z [M+] calcd for C10H18F2O3: 222.1068; found: 222.1074.

Synthesis of β-Keto-α,α-difluoro Ester via Dess–Martin Oxidation18

To a vial containing β-hydroxy-α,α-difluoro ester (19, 1.0 equiv) and Dess–Martin periodinane (1.2 equiv) was added DCM (8 mL/19) at ambient temperature under air. After the reaction was complete (monitored by TLC), the reaction mixture was quenched with 10% Na2S2O3-saturated K2CO3 aqueous solution and the mixture was stirred for 30 min. Then, the whole mixture was extracted with CHCl3. The extract was washed with saturated K2CO3 aqueous solution, followed by H2O, and dried with MgSO4, and then the filtrate was collected and concentrated in vacuo. The residue was purified by column chromatography on silica gel (EtOAc/C6) to afford the desired product 6.

Methyl 2,2-Difluoro-3-oxo-3-phenylpropanoate (6a)

Yield 85% (295.7 mg), colorless liquid. 1H NMR (400 MHz, CDCl3) δ 8.09–8.08 (m, 2H), 7.69–7.67 (m, 1H), 7.55–7.51 (m, 2H), 3.94 (s, 3H); 13C{1H} NMR (100 MHz, CDCl3) δ 185.4 (t, J = 27.5 Hz), 162.3 (t, J = 30.3 Hz), 135.2, 130.9, 130.0, 129.0, 109.9 (t, J = 264.9 Hz), 54.0; 19F NMR (376 MHz, CDCl3) δ −107.2 (s, 2F). MS m/z = 214 [M+]; HRMS (EI): m/z [M+] calcd for C10H8F2O3: 214.0442; found: 214.0445.

Methyl 2,2-Difluoro-3-(naphthalen-2-yl)-3-oxopropanoate (6b)

Yield 93% (493.0 mg), colorless liquid. 1H NMR (400 MHz, CDCl3) δ 8.67 (s, 1H), 8.07–7.89 (m, 4H), 7.68–7.61 (m, 2H), 3.95 (s, 3H); 13C{1H} NMR (100 MHz, CDCl3) δ 185.3 (t, J = 27.5 Hz), 162.5 (t, J = 30.8 Hz), 136.3, 133.0 (m), 132.2, 130.2, 129.9, 129.0, 128.2, 127.9, 127.3, 124.2, 110.2 (t, J = 264.9 Hz), 54.1; 19F NMR (376 MHz, CDCl3) δ −106.6 (s, 2F). MS m/z = 264 [M+]; HRMS (EI): m/z [M+] calcd for C14H10F2O3: 264.0598; found: 264.0601.

Methyl 2,2-Difluoro-3-(4-methoxyphenyl)-3-oxopropanoate (6c)

Yield 97% (340.4 mg), colorless liquid. 1H NMR (400 MHz, CDCl3) δ 8.08 (d, J = 8.2 Hz, 2H), 6.99 (d, J = 8.2 Hz, 2H), 3.93 (s, 3H), 3.91 (s, 3H); 13C{1H} NMR (100 MHz, CDCl3) δ 183.7 (t, J = 27.5 Hz), 165.2, 162.6 (t, J = 30.8 Hz), 132.6, 123.7, 114.3, 110.2 (t, J = 264.9 Hz), 55.7, 54.0; 19F NMR (376 MHz, CDCl3) δ −106.9 (s, 2F). MS m/z = 244 [M+]; HRMS (EI): m/z [M+] calcd for C11H10F2O4: 244.0547; found: 244.0545.

Methyl 3-(4-Chlorophenyl)-2,2-difluoro-3-oxopropanoate (6d)

Yield 73% (445.3 mg), colorless liquid. 1H NMR (400 MHz, CDCl3) δ 8.03 (d, J = 8.7 Hz, 2H), 7.51 (d, J = 8.7 Hz, 2H), 3.94 (s, 3H); 13C{1H} NMR (100 MHz, CDCl3) δ 184.4 (t, J = 27.9 Hz), 162.1 (t, J = 30.3 Hz), 142.1, 131.4 (m), 129.5, 129.2 (m), 109.8 (t, J = 265.4 Hz), 54.1; 19F NMR (376 MHz, CDCl3) δ −107.2 (s, 2F). MS m/z = 248 [M+]; HRMS (EI): m/z [M+] calcd for C10H7ClF2O3: 248.0052; found: 248.0056 (100), 249.9994 (31.5).

Methyl 2,2-Difluoro-3-oxo-5-phenylpentanoate (6e)

Yield 78% (437.0 mg), colorless liquid. 1H NMR (400 MHz, CDCl3) δ 7.32–7.28 (m, 2H), 7.24–7.19 (m, 3H), 3.87 (s, 3H), 3.08 (t, J = 7.2 Hz, 2H), 2.97 (t, J = 7.2 Hz, 2H); 13C{1H} NMR (100 MHz, CDCl3) δ 196.4 (t, J = 27.9 Hz), 161.7 (t, J = 30.8 Hz), 139.7, 128.7, 128.4, 126.5, 108.3 (t, J = 263.9 Hz), 54.0, 38.4, 28.4; 19F NMR (376 MHz, CDCl3) δ −113.6 (s, 2F). MS m/z = 242 [M+]; HRMS (EI): m/z [M+] calcd for C12H12F2O3: 242.0755; found: 242.0751.

Methyl 3-Cyclohexyl-2,2-difluoro-3-oxopropanoate (6f)

Yield 59% (336.3 mg), colorless liquid. 1H NMR (400 MHz, CDCl3) δ 3.91 (s, 3H), 2.94–2.88 (m, 1H), 1.92–1.69 (m, 5H), 1.46–1.22 (m, 5H); 13C{1H} NMR (100 MHz, CDCl3) δ 200.1 (t, J = 27.0 Hz), 162.1 (t, J = 30.8 Hz), 108.7 (t, J = 264.9 Hz), 53.9, 45.3, 28.0, 25.5, 25.3; 19F NMR (376 MHz, CDCl3) δ −112.8 (s, 2F). MS m/z = 220 [M+]; HRMS (EI): m/z [M+] calcd for C10H14F2O3: 220.0911; found: 220.0911.

General Procedure for Krapcho Decarboxylative Aldol Reaction

A flame-dried reaction vessel was cooled to room temperature and filled with argon. To this flask containing the corresponding β-keto-α,α-difluoro ester (6, 0.5 mmol), Yb(OTf)3·n-hydrate (0.75 mmol, 1.5 equiv), NaCl (0.75 mmol, 1.5 equiv), and aldehydes (0.5 mmol, 1.0 equiv) was added CH3CN (2.0 mL/6). Then, H2O (0.5 mmol, 1.0 equiv, 0.5 mL, 1.0 M in CH3CN) was added to the reaction mixture. Finally, the reaction mixture was heated to 100 °C and stirred for 18 h. The reaction mixture was cooled to room temperature, quenched with 10% aqueous HCl, and extracted with ethyl acetate. The extract was washed with brine and dried with MgSO4. The filtrate was collected and concentrated in vacuo. The residue was purified by column chromatography on silica gel (EtOAc/C6) to afford the desired product 4.

2,2-Difluoro-3-hydroxy-1,3-diphenylpropan-1-one (4aa)4c

Yield 95% (123.8 mg), colorless solid, mp 69.0–70.0 °C (from Et2O-petroleum ether). 1H NMR (400 MHz, CDCl3) δ 8.07–8.05 (m, 2H), 7.66–7.62 (m, 1H), 7.51–7.39 (m, 7H), 5.39 (ddd, J = 18.8, 5.7, 4.6 Hz, 1H), 2.99 (d, J = 4.6 Hz, 1H); 13C{1H} NMR (100 MHz, CDCl3) δ 190.9 (dd, J = 31.3, 29.4 Hz), 134.7, 134.6, 132.4, 130.2 (m), 129.0, 128.6, 128.3, 128.1, 115.7 (dd, J = 264.4, 256.7 Hz), 73.3 (dd, J = 28.9, 23.1 Hz); 19F NMR (376 MHz, CDCl3) δ −104.6 (dd, J = 293.0, 5.7 Hz, 1F), −116.4 (dd, J = 293.0, 18.8 Hz, 1F). MS m/z = 262 [M+]; HRMS (EI): m/z [M+] calcd for C15H12F2O2: 262.0805; found: 262.0807.

2,2-Difluoro-3-hydroxy-3-(naphthalen-2-yl)-1-phenylpropan-1-one (4ab)4b

Yield 96% (143.0 mg), colorless solid, mp 107.5–108.0 °C (from CHCl3–C6). 1H NMR (400 MHz, CDCl3) δ 8.06 (d, J = 7.3 Hz, 2H), 7.96 (s, 1H), 7.83–7.87 (m, 3H), 7.59–7.63 (m, 2H), 7.43–7.52 (m, 4H), 5.54 (ddd, J = 18.8, 5.8, 3.5 Hz, 1H), 3.19 (d, J = 3.5 Hz, 1H); 13C{1H} NMR (100 MHz, CDCl3) δ 190.9 (dd, J = 31.3, 29.4 Hz), 134.6, 133.6, 132.9, 132.4 (m), 132.2, 130.3 (m), 128.7, 128.3, 128.0, 127.8, 127.7, 126.5, 126.3, 125.3, 115.9 (dd, J = 264.9, 257.2 Hz), 73.4 (dd, J = 28.9, 23.1 Hz); 19F NMR (376 MHz, CDCl3) δ −104.2 (dd, J = 293.0, 5.8 Hz, 1F), −116.1 (dd, J = 293.0, 18.8 Hz, 1F). MS m/z = 312 [M+]; HRMS (EI): m/z [M+] calcd for C19H14F2O2: 312.0962; found: 312.0961.

2,2-Difluoro-3-hydroxy-3-(4-methoxyphenyl)-1-phenylpropan-1-one (4ac)4c,19

Yield 75% (109.8 mg), colorless liquid. 1H NMR (400 MHz, CDCl3) δ 8.04–8.06 (m, 2H), 7.61–7.65 (m, 1H), 7.41–7.50 (m, 4H), 6.92 (d, J = 6.6, 2.1 Hz, 2H), 5.33 (ddd, J = 18.3, 6.0, 4.6 Hz, 1H), 3.82 (s, 3H), 2.94 (d, J = 4.6 Hz, 1H); 13C{1H} NMR (100 MHz, CDCl3) δ 191.0 (dd, J = 31.8, 28.9 Hz), 160.1, 134.5, 132.5 (m), 130.2 (m), 129.4, 128.6, 126.8, 115.8 (dd, J = 263.9, 256.2 Hz), 113.8, 73.0 (dd, J = 27.9, 23.1 Hz), 55.3; 19F NMR (376 MHz, CDCl3) δ −105.0 (dd, J = 289.7, 6.0 Hz, 1F), −116.4 (dd, J = 289.7, 18.3 Hz, 1F). MS m/z = 292 [M+]; HRMS (EI): m/z [M+] calcd for C16H14F2O3: 292.0911; found: 292.0907.

2,2-Difluoro-3-hydroxy-1-phenyl-3-(p-tolyl)propan-1-one (4ad)4b,4c,19

Yield 89% (123.5 mg), colorless liquid. 1H NMR (400 MHz, CDCl3) δ 8.03–8.05 (m, 2H), 7.59–7.63 (m, 1H), 7.43–7.47 (m, 2H), 7.37 (d, J = 7.9 Hz, 2H), 7.19 (d, J = 7.9 Hz, 2H), 5.32 (ddd, J = 18.8, 5.2, 3.6 Hz, 1H), 3.05 (brd, J = 3.6 Hz, 1H), 2.35 (s, 3H); 13C{1H} NMR (100 MHz, CDCl3) δ 191.0 (dd, J = 31.8, 28.9 Hz), 138.9, 134.5, 132.5 (m), 131.8, 130.2 (m), 129.0, 128.6, 128.0, 115.8 (dd, J = 263.9, 256.2 Hz), 73.2 (dd, J = 28.9, 23.1 Hz), 21.2; 19F NMR (376 MHz, CDCl3) δ −104.8 (dd, J = 290.4, 5.2 Hz, 1F), −116.4 (dd, J = 290.4, 18.8 Hz, 1F). MS m/z = 276 [M+]; HRMS (EI): m/z [M+] calcd for C16H14F2O2: 276.0962; found: 276.0964.

2,2-Difluoro-3-hydroxy-1-phenyl-3-(m-tolyl)propan-1-one (4ae)4b,4c

Yield 93% (128.8 mg), colorless liquid. 1H NMR (400 MHz, CDCl3) δ 8.04–8.06 (m, 2H), 7.61–7.65 (m, 1H), 7.45–7.49 (m, 2H), 7.18–7.31 (m, 4H), 5.34 (ddd, J = 18.8, 5.4, 4.6 Hz, 1H), 2.99 (d, J = 4.6 Hz, 1H), 2.36 (s, 3H); 13C{1H} NMR (100 MHz, CDCl3) δ 191.0 (dd, J = 31.8, 28.9 Hz), 138.0, 134.7, 134.5, 132.5 (m), 130.2 (m), 129.8, 128.7, 128.6, 128.2, 125.2, 115.9 (dd, J = 263.9, 256.2 Hz), 73.3 (dd, J = 28.9, 23.1 Hz), 21.4; 19F NMR (376 MHz, CDCl3) δ −104.6 (dd, J = 289.6, 5.4 Hz, 1F), −116.3 (dd, J = 289.6, 18.8 Hz, 1F). MS m/z = 276 [M+]; HRMS (EI): m/z [M+] calcd for C16H14F2O2: 276.0962; found: 276.0966.

2,2-Difluoro-3-hydroxy-1-phenyl-3-(o-tolyl)propan-1-one (4af)4b,4c

Yield 93% (128.4 mg), colorless liquid. 1H NMR (400 MHz, CDCl3) δ 8.07 (d, J = 7.3 Hz, 2H), 7.61–7.64 (m, 2H), 7.47 (m, 2H), 7.17–7.28 (m, 3H), 5.69 (dd, J = 19.9, 3.3 Hz, 1H), 2.97 (brs, 1H), 2.38 (s, 3H); 13C{1H} NMR (100 MHz, CDCl3) δ 191.1 (dd, J = 31.8, 28.9 Hz), 136.8, 134.6, 133.3, 132.4 (m), 130.4, 130.3 (m), 128.8, 128.7, 128.1 (m), 126.1, 116.4 (dd, J = 265.4, 255.8 Hz), 68.9 (dd, J = 29.9, 23.1 Hz), 19.6, 19.5; 19F NMR (376 MHz, CDCl3) δ −104.0 (dd, J = 293.7, 3.3 Hz, 1F), −116.9 (dd, J = 293.7, 19.9 Hz, 1F). MS m/z = 276 [M+]; HRMS (EI): m/z [M+] calcd for C16H14F2O2: 276.0962; found: 276.0963.

2,2-Difluoro-3-hydroxy-3-mesityl-1-phenylpropan-1-one (4ag)4c,19

Yield 47% (71.2 mg), colorless liquid. 1H NMR (400 MHz, CDCl3) δ 8.10–8.11 (m, 2H), 7.47–7.66 (m, 3H), 6.89 (s, 2H), 5.91 (ddd, J = 26.3, 4.6, 3.0 Hz, 1H), 2.80 (m, 1H), 2.46 (brs, 6H), 2.28 (s, 3H); 13C{1H} NMR (100 MHz, CDCl3) δ 191.6 (dd, J = 32.8, 28.9 Hz), 138.2, 134.5, 132.5 (m), 130.3 (m), 128.7, 127.7, 117.7 (dd, J = 268.3, 252.9 Hz), 70.6 (dd, J = 30.8, 23.1 Hz), 21.2, 20.8; 19F NMR (376 MHz, CDCl3) δ −102.0 (d, J = 292.6 Hz, 1F), −114.6 (dd, J = 292.6, 27.5 Hz, 1F). MS m/z = 304 [M+]; HRMS (EI): m/z [M+] calcd for C18H18F2O2: 304.1275; found: 304.1280.

2,2-Difluoro-3-(4-fluorophenyl)-3-hydroxy-1-phenylpropan-1-one (4ah)19

Yield 94% (131.8 mg), colorless solid, mp 75.5–76.2 °C (from Et2O–C6). 1H NMR (400 MHz, CDCl3) δ 8.05–8.06 (m, 2H), 7.62–7.66 (m, 1H), 7.46–7.50 (m, 4H), 7.08 (m, 2H), 5.37 (dd, J = 18.8, 5.2 Hz, 1H), 3.13 (brs, 1H); 13C{1H} NMR (100 MHz, CDCl3) δ 190.8 (dd, J = 31.8, 29.9 Hz), 163.2 (d, J = 247.6 Hz), 134.8, 132.2 (m), 130.4 (m), 130.3 (m), 129.9 (d, J = 8.7 Hz), 128.7, 115.4 (dd, J = 264.9, 257.2 Hz), 115.3 (d, J = 22.2 Hz), 72.6 (dd, J = 28.9, 23.1 Hz); 19F NMR (376 MHz, CDCl3) δ −104.5 (dd, J = 295.0, 5.2 Hz, 1F), −112.7 (m, 1F), −116.7 (dd, J = 295.0, 18.8 Hz, 1F). MS m/z = 280 [M+]; HRMS (EI): m/z [M+] calcd for C15H11F3O2: 280.0711; found: 280.0709.

3-(4-Chlorophenyl)-2,2-difluoro-3-hydroxy-1-phenylpropan-1-one (4ai)4b

Yield 96% (143.0 mg), colorless solid, mp 96.5–97.0 °C (from Et2O–C6). 1H NMR (400 MHz, CDCl3) δ 8.06 (d, J = 8.4 Hz, 2H), 7.62–7.66 (m, 1H), 7.43–7.50 (m, 4H), 7.36 (d, J = 8.4 Hz, 2H), 5.36 (dd, J = 18.8, 5.0 Hz, 1H), 3.18 (brs, 1H); 13C{1H} NMR (100 MHz, CDCl3) δ 190.7 (dd, J = 31.8, 28.9 Hz), 135.0, 134.8, 133.1, 132.2 (m), 130.3 (m), 129.5, 128.7, 128.5, 115.4 (dd, J = 264.9, 257.2 Hz), 72.6 (dd, J = 28.9, 23.1 Hz); 19F NMR (376 MHz, CDCl3) δ −104.2 (dd, J = 296.2, 5.0 Hz, 1F), −116.6 (dd, J = 296.2, 18.8 Hz, 1F). MS m/z = 296 [M+]; HRMS (EI): m/z [M+] calcd for C15H11ClF2O2: 296.0416; found: 296.0408 (100), 298.0394 (34.3).

Methyl 4-(2,2-Difluoro-1-hydroxy-3-oxo-3-phenylpropyl)benzoate (4aj)4c,19

Yield 87% (139.5 mg), colorless solid, mp 94.0–94.6 °C (from CHCl3–C6). 1H NMR (400 MHz, CDCl3) δ 8.07 (d, J = 7.8 Hz, 4H), 7.63–7.67 (m, 1H), 7.59 (d, J = 7.8 Hz, 2H), 7.47–7.51 (m, 2H), 5.46 (ddd, J = 19.2, 5.2, 4.6 Hz, 1H), 3.93 (s, 3H), 3.19 (d, J = 4.6 Hz, 1H); 13C{1H} NMR (100 MHz, CDCl3) δ190.6 (dd, J = 31.8, 29.9 Hz), 166.8, 139.6, 134.8, 132.1 (m), 130.6, 130.3 (m), 129.5, 128.7, 128.2, 115.5 (dd, J = 265.9, 257.2 Hz), 72.8 (dd, J = 27.9, 23.1 Hz), 52.2; 19F NMR (376 MHz, CDCl3) δ −103.9 (dd, J = 296.0, 5.2 Hz, 1F), −116.4 (dd, J = 296.0, 19.2 Hz, 1F). MS m/z = 320 [M+]; HRMS (EI): m/z [M+] calcd for C17H14F2O4: 320.0860; found: 320.0866.

2,2-Difluoro-3-hydroxy-3-(4-nitrophenyl)-1-phenylpropan-1-one (4ak)4b,4c

Yield 82% (125.9 mg), colorless solid, mp 114.5–115.5 °C (from CHCl3). 1H NMR (400 MHz, CDCl3) δ 8.26 (d, J = 6.9 Hz, 2H), 8.07–8.09 (m, 2H), 7.65–7.72 (m, 3H), 7.49–7.53 (m, 2H), 5.53 (ddd, J = 19.3, 4.3, 4.1 Hz, 1H), 3.38 (d, J = 4.1 Hz, 1H); 13C{1H} NMR (100 MHz, CDCl3) δ 190.3 (dd, J = 31.8, 29.9 Hz), 148.3, 141.7, 135.1, 131.7 (m), 130.3 (m), 129.2, 128.9, 123.3, 115.0 (dd, J = 266.8, 258.2 Hz), 72.2 (dd, J = 27.9, 23.1 Hz); 19F NMR (376 MHz, CDCl3) δ −103.3 (dd, J = 302.0, 4.3 Hz, 1F), −116.5 (dd, J = 302.0, 19.3 Hz, 1F). MS m/z = 307 [M+]; HRMS (EI): m/z [M+] calcd for C15H11F2NO4: 307.0656; found: 307.0659.

2,2-Difluoro-3-hydroxy-1-phenyl-3-(4-(trifluoromethyl)phenyl)propan-1-one (4al)4c

Yield 98% (161.4 mg), colorless solid, mp 103.0–104.0 °C (from CHCl3). 1H NMR (400 MHz, CDCl3) δ 8.08 (d, J = 7.3 Hz, 2H), 7.63–7.68 (m, 5H), 7.48–7.52 (m, 2H), 5.47 (ddd, J = 19.1, 5.1, 4.6 Hz, 1H), 3.20 (d, J = 4.6 Hz, 1H); 13C{1H} NMR (100 MHz, CDCl3) δ 190.5 (dd, J = 31.8, 29.9 Hz), 138.6, 134.9, 132.0 (m), 131.1 (q, J = 32.8 Hz), 130.3 (m), 128.8, 128.6, 125.2 (q, J = 3.5 Hz), 124.0 (q, J = 271.9 Hz), 115.28 (dd, J = 265.9, 257.2 Hz), 72.61 (dd, J = 28.9, 23.1 Hz); 19F NMR (376 MHz, CDCl3) δ −62.6 (s, 3F), −103.8 (dd, J = 299.7, 5.1 Hz, 1F), −116.5 (dd, J = 299.7, 19.1 Hz, 1F). MS m/z = 330 [M+]; HRMS (EI): m/z [M+] calcd for C16H11F5O2: 330.0679; found: 330.0673.

2,2-Difluoro-3-hydroxy-1-phenyl-3-(pyridin-2-yl)propan-1-one (4am)4c

Yield 10% (13.0 mg), colorless solid, mp 70.5–71.0 °C. 1H NMR (400 MHz, CDCl3) δ 8.59–8.61 (m, 1H), 8.08–8.10 (m, 2H), 7.76–7.78 (m, 1H), 7.46–7.62 (m, 4H), 7.33–7.36 (m, 1H), 5.37 (dd, J = 17.8, 4.8 Hz, 2H) (Note: the OH and methine proton were overlapped); 13C{1H} NMR (100 MHz, CDCl3) δ 190.4 (dd, J = 29.9, 27.0 Hz), 152.4, 148.1, 137.0, 134.1, 133.3 (m), 130.3 (m), 128.5, 124.0, 123.1 (m), 116.8 (dd, J = 263.9, 257.2 Hz), 71.84 (dd, J = 28.9, 25.0 Hz); 19F NMR (376 MHz, CDCl3) δ −104.8 (dd, J = 272.0, 4.8 Hz, 1F), −116.7 (dd, J = 272.0, 17.7 Hz, 1F). MS m/z = 263 [M+]; HRMS (EI): m/z [M+] calcd for C14H11F2NO2: 263.0758; found: 263.0754.

2,2-Difluoro-3-hydroxy-1-phenyl-3-(pyridin-3-yl)propan-1-one (4an)

Yield 75% (99.3 mg), colorless solid, mp 103.0–104.0 °C. 1H NMR (400 MHz, CDCl3) δ 8.65 (s, 1H), 8.55 (d, J = 4.6 Hz, 1H), 8.09 (d, J = 7.3 Hz, 2H), 7.90 (d, J = 8.2 Hz, 1H), 7.64–7.68 (m, 1H), 7.48–7.52 (m, 2H), 7.33–7.36 (m, 1H), 5.43 (dd, J = 19.4, 4.8 Hz, 1H), 4.17 (brs, 1H); 13C{1H} NMR (100 MHz, CDCl3) δ 190.7 (dd, J = 31.3, 27.5 Hz), 149.1, 148.8, 136.6, 134.5, 132.7, 132.3, 130.2, 128.7, 123.5, 116.1 (dd, J = 264.9, 256.2 Hz), 70.8 (dd, J = 28.9, 23.1 Hz); 19F NMR (376 MHz, CDCl3) δ −103.7 (dd, J = 297.3, 4.8 Hz, 1F), −116.8 (dd, J = 297.7, 19.4 Hz, 1F). MS m/z = 263 [M+]; HRMS (EI): m/z [M+] calcd for C14H11F2NO2: 263.0758; found: 263.0760.

3-Cyclohexyl-2,2-difluoro-3-hydroxy-1-phenylpropan-1-one (4ao)4c

Yield 62% (82.7 mg), colorless liquid. 1H NMR (400 MHz, CDCl3) δ 8.07–8.09 (m, 2H), 7.61–7.64 (m, 1H), 7.46–7.50 (m, 2H), 4.01–4.09 (m, 1H), 2.52 (brs, 1H), 1.96–1.98 (m, 1H), 1.65–1.83 (m, 5H), 1.12–1.39 (m, 5H); 13C{1H} NMR (100 MHz, CDCl3) δ 190.9 (dd, J = 31.3, 29.4 Hz), 134.4, 132.53 (m), 130.2 (m), 128.7, 117.8 (dd, J = 263.0, 257.2 Hz,), 74.8 (dd, J = 27.0, 23.1 Hz), 38.1, 30.1, 27.3, 26.3, 26.1, 25.9; 19F NMR (376 MHz, CDCl3) δ −104.8 (d, J = 288.3 Hz, 1F), −114.5 (dd, J = 288.3, 20.2 Hz, 1F). MS m/z = 268 [M+]; HRMS (EI): m/z [M+] calcd for C15H18F2O2: 268.1275; found: 268.1273.

2,2-Difluoro-3-hydroxy-1,5-diphenylpentan-1-one (4ap)4b,4c

Yield 44% (63.2 mg), colorless liquid. 1H NMR (400 MHz, CDCl3) δ 8.10–8.08 (m, 2H), 7.66–7.62 (m, 1H), 7.51–7.47 (m, 2H), 7.31–7.18 (m, 5H), 4.29–4.19 (m, 1H), 3.02–2.95 (m, 1H), 2.80–2.72 (m, 1H), 2.63 (d, J = 5.5 Hz, 1H), 2.12–1.95 (m, 2H); 13C{1H} NMR (100 MHz, CDCl3) δ 190.5 (dd, J = 32.3, 30.3 Hz), 141.1, 134.7, 132.0, 130.3 (m), 128.7, 128.5, 126.1, 116.4 (dd, J = 262.0, 258.2 Hz), 70.4 (dd, J = 27.0, 24.1 Hz), 31.3, 30.2; 19F NMR (376 MHz, CDCl3) δ −107.3 (dd, J = 298.2, 5.4 Hz, 1F), −116.9 (dd, J = 298.2, 18.1 Hz, 1F). MS m/z = 290 [M+]; HRMS (EI): m/z [M+] calcd for C17H16F2O2: 290.1118; found: 290.1118.

2,2-Difluoro-3-hydroxy-3-methyl-1-phenylbutan-1-one (4aq)4c

Yield 63% (66.4 mg), colorless liquid. 1H NMR (400 MHz, CDCl3) δ 8.13–8.11 (m, 2H), 7.65–7.61 (m, 1H), 7.51–7.47 (m, 2H), 3.01 (brs, 1H), 1.44 (t, J = 1.4 Hz, 6H); 13C{1H} NMR (100 MHz, CDCl3) δ 191.3 (t, J = 31.8 Hz), 134.6, 133.2 (m), 130.5 (m), 128.7, 117.2 (t, J = 262.0 Hz), 73.4 (t, J = 24.6 Hz), 23.7 (t, J = 2.9 Hz); 19F NMR (376 MHz, CDCl3) δ −110.5 (s, 2F). MS m/z = 214 [M+]; HRMS (EI): m/z [M+] calcd for C11H12F2O2: 214.0805; found: 214.0808.

2,2-Difluoro-3-hydroxy-1-(naphthalen-2-yl)-3-phenylpropan-1-one (4ba)20

Yield 83% (129.9 mg), colorless solid, mp 122.5–123.5 °C (from CHCl3–C6). 1H NMR (400 MHz, CDCl3) δ 8.61 (s, 1H), 8.03 (d, J = 8.7 Hz, 1H), 7.85–7.92 (m, 3H), 7.52–7.64 (m, 4H), 7.37–7.42 (m, 3H), 5.43 (ddd, J = 18.8, 5.8, 4.3 Hz, 1H), 3.15 (d, J = 3.7 Hz, 1H); 13C{1H} NMR (100 MHz, CDCl3) δ 190.7 (dd, J = 31.8, 28.9 Hz), 136.1, 134.7, 133.3 (m), 132.2, 130.2, 129.5, 129.1, 128.5, 128.3, 128.2, 127.8, 127.0, 124.7, 115.9 (dd, J = 264.4, 256.7 Hz), 73.4 (dd, J = 27.9, 23.1 Hz); 19F NMR (376 MHz, CDCl3) δ −103.9 (dd, J = 291.9, 5.8 Hz, 1F), −115.4 (dd, J = 291.9, 18.8 Hz, 1F). MS m/z = 312 [M+]; HRMS (EI): m/z [M+] calcd for C19H14F2O2: 312.0962; found: 312.0965.

2,2-Difluoro-3-hydroxy-1-(4-methoxyphenyl)-3-phenylpropan-1-one (4ca)4c,20

Yield 90% (130.7 mg), colorless solid, mp 119.5–120.5 °C (from Et2O–C6). 1H NMR (400 MHz, CDCl3) δ 8.05–8.07 (m, 2H), 7.37–7.50 (m, 5H), 6.93 (d, J = 9.2 Hz, 2H), 5.36 (ddd, J = 19.1, 5.5, 4.6 Hz, 1H), 3.88 (s, 3H), 3.21 (d, J = 4.6 Hz, 1H); 13C{1H} NMR (100 MHz, CDCl3) δ 189.1 (dd, J = 30.8, 28.9 Hz), 164.8, 134.8, 132.9 (m), 128.9, 128.3, 128.2, 125.1 (m), 115.8 (dd, J = 264.9, 257.2 Hz), 114.0, 73.4 (dd, J = 27.9, 23.1 Hz), 55.6; 19F NMR (376 MHz, CDCl3) δ −103.9 (dd, J = 293.5, 5.5 Hz, 1F), −115.8 (dd, J = 293.5, 19.1 Hz, 1F). MS m/z = 292 [M+]; HRMS (EI): m/z [M+] calcd for C16H14F2O3: 292.0911; found: 292.0905.

1-(4-Chlorophenyl)-2,2-difluoro-3-hydroxy-3-phenylpropan-1-on (4da)4c,20

Yield 75% (111.2 mg), colorless solid, mp 111.5–112.5 °C (from Et2O–C6). 1H NMR (400 MHz, CDCl3) δ 7.98 (d, J = 8.7 Hz, 2H), 7.38–7.49 (m, 7H), 5.35 (ddd, J = 18.4, 5.8, 4.6 Hz, 1H), 3.00 (d, J = 4.6 Hz, 1H); 13C{1H} NMR (100 MHz, CDCl3) δ 189.9 (dd, J = 31.8, 28.9 Hz), 141.4, 134.5, 131.6 (m), 130.7 (m), 129.2, 129.1, 128.7, 128.5, 128.4, 128.1, 115.7 (dd, J = 263.9, 256.2 Hz), 73.2 (dd, J = 27.9, 23.1 Hz); 19F NMR (376 MHz, CDCl3) δ −104.7 (dd, J = 290.5, 5.8 Hz, 1F), −116.4 (dd, J = 290.5, 18.4 Hz, 1F). MS m/z = 296 [M+]; HRMS (EI): m/z [M+] calcd for C15H11ClF2O2: 296.0416; found: 296.0420 (31.8), 298.0390 (11.7).

2,2-Difluoro-1-hydroxy-1,5-diphenylpentan-3-one (4ea)21

Yield 69% (100.7 mg), colorless solid, mp 64.5–65.0 °C (from Et2O–C6). 1H NMR (400 MHz, CDCl3) δ 7.35–7.40 (m, 5H), 7.12–7.28 (m, 5H), 5.11 (dd, J = 16.5, 7.8 Hz, 1H), 2.84–3.01 (m, 4H), 2.70 (brs, 1H); 13C{1H} NMR (100 MHz, CDCl3) δ 201.5 (dd, J = 31.3, 27.5 Hz), 140.0, 134.6, 129.2, 128.5, 128.5, 128.3, 127.7, 126.3, 114.8 (dd, J = 261.5, 255.8 Hz), 73.2 (dd, J = 27.9, 24.1 Hz), 39.8, 28.4; 19F NMR (376 MHz, CDCl3) δ −113.3 (dd, J = 268.4, 7.8 Hz, 1F), −122.7 (dd, J = 268.4, 16.5 Hz, 1F). MS m/z = 290 [M+]; HRMS (EI): m/z [M+] calcd for C17H16F2O2: 290.1118; found: 290.1114.

1-Cyclohexyl-2,2-difluoro-3-hydroxy-3-phenylpropan-1-one (4fa)4c,19

This reaction was stirred for 48 h. Yield 59% (78.5 mg), colorless solid, mp 62.0–63.0 °C (from Et2O–C6). 1H NMR (400 MHz, CDCl3) δ 7.37–7.42 (m, 5H), 5.17 (ddd, J = 16.6, 7.7, 3.8 Hz, 1H), 2.72–2.78 (m, 2H), 1.16–1.84 (m, 10H); 13C{1H} NMR (100 MHz, CDCl3) δ 205.6 (dd, J = 30.3, 26.5 Hz), 134.8 (m), 129.1, 128.4, 127.8, 115.0 (dd, J = 263.0, 256.2 Hz), 73.0 (dd, J = 28.4, 23.6 Hz), 45.8, 27.9, 27.7, 25.5, 25.3, 25.2; 19F NMR (376 MHz, CDCl3) δ −112.4 (dd, J = 272.5, 7.7 Hz, 1F), −122.4 (dd, J = 272.5, 16.6 Hz, 1F). MS m/z = 268 [M+]; HRMS (EI): m/z [M+] calcd for C15H18F2O2: 268.1275; found: 268.1279.

Synthetic Utility of α,α-Difluoro-β-keto Ester

Methyl 3-(Adamantan-1-yl)-2,2-difluoro-3-oxopropanoate (11)

1-Adamantanemethanol (8) was obtained by a reported procedure.22 The product 8 was purified via only filtration and solvent washing to afford 3.286 g of 8 in 99% yield as a colorless solid. To a vial containing 1-adamantanemethanol (8, 831.3 mg, 5 mmol) was added DCM (30 mL) at ambient temperature. Dess–Martin periodinane (DMP, 3.18 g, 7.5 mmol, 1.5 equiv) was added to the solution, and the mixture was stirred. To the whole mixture was added a wet DCM (0.4%, DCM/H2O = 50/0.2 mL) dropwise over the period of 1.5 h. The reaction mixture was stirred for 0.5 h and then diluted to 200 mL with diethyl ether. The dilution was concentrated by rotary evaporation to approximately 30 mL. Unreacted DMP was removed through Celite filtration, and the filtrate was washed with 1:1 mixture of 10% Na2S2O3 and saturated aqueous NaHCO3. The aqueous layer was extracted with ether, and then the combined organic layers were washed with brine. The extract was dried over MgSO4 and concentrated in vacuo to afford 1-adamantane carboxaldehyde 9 as an oil.22 The intermediate 9 was used immediately without any purification. The Reformatky reaction of 9 with methyl bromodifluoroacetate was conducted via above representative Honda–Reformatsky reaction (see the typical procedure of Honda–Reformatsky reaction). A solution of 9, methyl bromodifluoroacetate (0.83 mL, 7.5 mmol), and RhCl(PPh3)3 (46.3 mg, 1 mol %) in CH3CN (40 mL) was treated with Et2Zn (7.5 mL, 1 M solution in C6). The Reformatsky product 10 was isolated and purified by column chromatography on silica gel (EtOAc/C6 = 1:4) to give a liquid in 52% yield (709.4 mg, 2.59 mmol, two steps from 8). The obtaining 10 was oxidized via above representative Dess–Martin oxidation (See typical procedure of Dess–Martin oxidation reaction). A solution of 10 (685.8 mg, 2.5 mmol) in DCM (20 mL) was treated with DMP (1.27 g, 3 mmol, 1.2 equiv). The titled compound 11 was isolated and purified by column chromatography on silica gel (EtOAc/C6 = 1:9) to give a colorless liquid in 82% yield (555.8 mg). 1H NMR (400 MHz, CDCl3) δ 3.90 (s, 3H), 2.07 (s, 3H), 1.98 (d, J = 2.7 Hz, 6H), 1.71–1.79 (m, 6H); 13C{1H} NMR (100 MHz, CDCl3) δ 200.4 (t, J = 25.5 Hz), 162.3 (t, J = 30.8 Hz), 110.3 (t, J = 267.3 Hz), 53.8, 46.5, 37.1, 36.3, 27.6; 19F NMR (376 MHz, CDCl3) δ −108.5 (s, 2F). MS m/z = 272 [M+]; HRMS (EI): m/z [M+] calcd for C14H18F2O3: 272.1224; found: 272.1219.

3-(4-Acetylphenyl)-1-(adamantan-1-yl)-2,2-difluoro-3-hydroxypropan-1-one (12)23

See representative procedure for the key Krapcho decarboxylative aldol reaction of 6. Methyl 3-(adamantan-1-yl)-2,2-difluoro-3-oxopropanoate 11 (136.1 mg, 0.5 mmol) was used, and the title compound was obtained by column chromatography on silica gel (EtOAc/C6 = 1:3) to give a colorless solid in 17% yield (31 mg). Mp 88.0–88.5 °C (from CHCl3–C6). 1H NMR (400 MHz, CDCl3) δ 7.95 (d, J = 8.2 Hz, 2H), 7.54 (d, J = 8.2 Hz, 2H), 5.33 (dd, J = 18.3, 6.2 Hz, 1H), 3.31 (brs, 1H), 2.61 (s, 3H), 2.03 (brs, 3H), 1.90 (brs, 6H), 1.67–1.76 (m, 6H); 13C{1H} NMR (100 MHz, CDCl3) δ 205.4 (dd, J = 29.4, 25.5 Hz), 198.1, 140.4, 137.3, 128.3, 128.1, 116.3 (dd, J = 267.8, 259.1 Hz), 72.6 (dd, J = 27.9, 23.1 Hz), 46.8 (t, J = 2.4 Hz), 36.8, 36.3, 27.6, 26.7; 19F NMR (376 MHz, CDCl3) δ −105.8 (dd, J = 290.4, 6.2 Hz, 1F), −118.7 (dd, J = 290.4, 18.3 Hz, 1F). MS m/z = 362 [M+]; HRMS (EI): m/z [M+] calcd for C21H24F2O3: 362.1694; found: 362.1699.

Acknowledgments

We would like to thank Editage (www.editage.jp) for English language editing.

Supporting Information Available

The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsomega.4c02105.

  • Further detail screening of Lewis acids and the loading of it, spectral data of all compounds including 1H, 13C, and 19F NMR spectra (PDF)

The authors declare no competing financial interest.

Supplementary Material

ao4c02105_si_001.pdf (9.6MB, pdf)

References

  1. a Müller K.; Faeh C.; Diederich F. Fluorine in Pharmaceuticals: Looking Beyond Intuition. Science. 2007, 317, 1881–1886. 10.1126/science.1131943. [DOI] [PubMed] [Google Scholar]; b Pettersson M.; Hou X.; Kuhn M.; Wager T. T.; Kauffman G. W.; Verhoest P. R. Quantitative Assessment of the Impact of Fluorine Substitution on P-Glycoprotein (P-gp) Mediated Efflux, Permeability, Lipophilicity, and Metabolic Stability. J. Med. Chem. 2016, 59, 5284–5296. 10.1021/acs.jmedchem.6b00027. [DOI] [PubMed] [Google Scholar]; c Marzi L.; Agama K.; Murai J.; Difilippantonio S.; James A.; Peer C. J.; Figg W. D.; Beck D.; Elsayed M. S. A.; Cushman M.; Pommier Y. Novel Fluoroindenoisoquinoline Non-Camptothecin Topoisomerase I Inhibitors. Mol. Cancer Ther. 2018, 17, 1694–1704. 10.1158/1535-7163.MCT-18-0028. [DOI] [PMC free article] [PubMed] [Google Scholar]; d Seitz J. D.; Vineberg J. G.; Wei L.; Khan J. F.; Lichtenthal B.; Lin C.-F.; Ojima I. Design, Synthesis and Application of Fluorine-Labeled Toxoids as 19F NMR Probes for the Metabolic Stability Assessment of Tumor Targeted Drug Delivery Systems. J. Fluor. Chem. 2015, 171, 148–161. 10.1016/j.jfluchem.2014.08.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. a O’Hagan D. Understanding Organofluorine Chemistry. An Introduction to the C–F Bond. Chem. Soc. Rev. 2008, 37, 308–319. 10.1039/B711844A. [DOI] [PubMed] [Google Scholar]; b Gijsen H. J. M.; Alonso de Diego S. A.; De Cleyn M.; García-Molina A.; Macdonald G. J.; Martínez-Lamenca C.; Oehlrich D.; Prokopcova H.; Rombouts F. J. R.; Surkyn M.; Trabanco A. A.; Van Brandt S.; Van den Bossche D.; Van Gool M.; Austin N.; Borghys H.; Dhuyvetter D.; Moechars D. Optimization of 1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors Toward a Clinical Candidate. J. Med. Chem. 2018, 61, 5292–5303. 10.1021/acs.jmedchem.8b00304. [DOI] [PubMed] [Google Scholar]; c Zhang Q. W.; Brusoe A. T.; Mascitti V.; Hesp K. D.; Blakemore D. C.; Kohrt J. T.; Hartwig J. F. Fluorodecarboxylation for the Synthesis of Trifluoromethyl Aryl Ethers. Angew. Chem., Int. Ed. 2016, 55, 9758–9762. 10.1002/anie.201604793. [DOI] [PubMed] [Google Scholar]
  3. a Middleton W. J.; Bingham E. M. α,α-Difluoroarylacetic Acids: Preparation from (Diethylamino)Sulfur Trifluoride and α-oxoarylacetates. J. Org. Chem. 1980, 45, 2883–2887. 10.1021/jo01302a025. [DOI] [Google Scholar]; b Umemoto T.; Singh R. P.; Xu Y.; Saito N. Discovery of 4-tert-Butyl-2,6-Dimethylphenylsulfur Trifluoride as a Deoxofluorinating Agent with High Thermal Stability as well as Unusual Resistance to Aqueous Hydrolysis, and Its Diverse Fluorination Capabilities Including Deoxofluoro-Arylsulfinylation with High Stereoselectivity. J. Am. Chem. Soc. 2010, 132, 18199–18205. 10.1021/ja106343h. [DOI] [PubMed] [Google Scholar]
  4. a Yuan J. W.; Liu S. N.; Mai W. P. Copper-Catalysed Difluoroalkylation of Aromatic Aldehydes via a Decarboxylation/Aldol Reaction. Org. Biomol. Chem. 2017, 15, 7654–7659. 10.1039/C7OB01739A. [DOI] [PubMed] [Google Scholar]; b Huang D.-K.; Lei Z. L.; Zhu Y.-J.; Liu Z. J.; Hu X.-J.; Mao H.-F. An Expedient Synthesis of α,α-Difluoro-β-Hydroxy Ketones via Decarboxylative Aldol Reaction of α,α-Difluoro-β-Keto Acids with Aldehydes. Tetrahedron Lett. 2017, 58, 3394–3397. 10.1016/j.tetlet.2017.07.060. [DOI] [Google Scholar]; c Tarui A.; Oduti M.; Shinya S.; Sato K.; Omote M. Decarboxylative Aldol Reaction of α,α-Difluoro-β-Ketocarboxylate Salt: a Facile Method for Generation of Difluoroenolate. RSC Adv. 2018, 8, 20568–20575. 10.1039/C8RA02440E. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Kikushima K.; Yamada K.; Umekawa N.; Yoshio N.; Kita Y.; Dohi T. Decarboxylative Arylation with diaryliodonium(III) Salts: Alternative Approach for Catalyst-Free Difluoroenolate Coupling to Aryldifluoromethyl Ketones. Green Chem. 2023, 25, 1790–1796. 10.1039/D2GC04445E. [DOI] [Google Scholar]
  6. Rodríguez N.; Goossen L. J. Decarboxylative Coupling Reactions: a Modern Strategy for C–C-Bond Formation. Chem. Soc. Rev. 2011, 40, 5030–5048. 10.1039/c1cs15093f. [DOI] [PubMed] [Google Scholar]
  7. a Wang Z.-L. Recent Advances in Catalytic Asymmetric Decarboxylative Addition Reactions. Adv. Synth. Catal. 2013, 355, 2745–2755. 10.1002/adsc.201300375. [DOI] [Google Scholar]; b Kawanishi R.; Hattori S.; Iwasa S.; Shibatomi K. Amine-Catalyzed Decarboxylative Aldol Reaction of β-Ketocarboxylic Acids with Trifluoropyruvates. Molecules. 2019, 24, 2773–2784. 10.3390/molecules24152773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Krapcho A. P.; Weimaster J. F.; Eldridge J. M.; Jahngen E. G. E. Jr.; Lovey A. J.; Stephens W. P. Synthetic Applications and Mechanism Studies of the Decarbalkoxylations of Geminal Diesters and Related Systems Effected in Me2SO by Water and/or by Water with Added Salts. J. Org. Chem. 1978, 43, 138–147. 10.1021/jo00395a032. [DOI] [Google Scholar]
  9. a Schepens W.; Van Haver D.; Vandewalle M.; Bouillon R.; Verstuyf A.; De Clercq P. J. Synthesis of Spiro[4.5]Decane CF-Ring Analogues of 1α,25-Dihydroxyvitamin D3. Org. Lett. 2006, 8, 4247–4250. 10.1021/ol061575p. [DOI] [PubMed] [Google Scholar]; b Poon P. S.; Banerjee A. K.; Laya M. S. Advances in the Krapcho Decarboxylation. J. Chem. Res. 2011, 35, 67–73. 10.3184/174751911X12964930076403. [DOI] [Google Scholar]; c Lee S.; Kim H.-S.; Min H.; Pyo A. One-Pot Synthesis of Benzoylacetonitriles Through Sequential Pd-Catalyzed Carbonylation and Decarboxylation. Tetrahedron Lett. 2016, 57, 239–242. 10.1016/j.tetlet.2015.12.050. [DOI] [Google Scholar]
  10. Langlois B. R.; Roques N. Nucleophilic Trifluoromethylation of Aryl Halides with Methyl Trifluoroacetate. J. Fluor. Chem. 2007, 128, 1318–1325. 10.1016/j.jfluchem.2007.08.001. [DOI] [Google Scholar]
  11. a Zhu F.; Xu P. W.; Zhou F.; Wang C. H.; Zhou J. Recycle Waste Salt as Reagent: A One-Pot Substitution/Krapcho Reaction Sequence to α-Fluorinated Esters and Sulfones. Org. Lett. 2015, 17, 972–975. 10.1021/acs.orglett.5b00072. [DOI] [PubMed] [Google Scholar]; b Chandran R.; Tiwari K. N. Krapcho Dealkoxycarbonylation Strategy of Ethyl Cyanoacetate for the Synthesis of 3-Hydroxy-3-cyanomethyl-2-oxindoles and 3,3′-Dicyanomethyl-2-oxindoles in a Reaction with Isatin. Synthesis 2020, 52, 2233–2240. 10.1055/s-0040-1707816. [DOI] [Google Scholar]
  12. See the Supporting Information: complete screening table of Lewis acids in Table S1.
  13. See the Supporting Information for the further optimization including the screening of the Lewis acids (Table S2).
  14. Sato K.; Tarui A.; Kita T.; Ishida Y.; Tamura H.; Omote M.; Ando A.; Kumadaki I. Rhodium-catalyzed Reformatsky-type reaction of ethyl bromodifuoroacetate. Tetrahedron Lett. 2004, 45, 5735–5737. 10.1016/j.tetlet.2004.05.099. [DOI] [Google Scholar]
  15. Blond G.; Billard T.; Langlois B. R. Generation and Use of an Equivalent of Difluoroacetamide or Difluoroacetate Anions. Chem.—Eur. J. 2002, 8, 2917–2922. . [DOI] [PubMed] [Google Scholar]
  16. Braun M.; Vonderhagen A.; Waldmüller D. Enantioselective Reformatsky Reaction of Methyl Bromodifluoroacetate. Liebigs Ann. 1995, 8, 1447–1450. 10.1002/jlac.1995199508196. [DOI] [Google Scholar]
  17. Kitagawa O.; Taguchi T.; Kobayashi Y. Aldol Reaction of Iododifluoroacetate-Zn and 2,2-Difluoroketene Silyl Acetal. Tetrahedron Lett. 1988, 29, 1803–1806. 10.1016/S0040-4039(00)82048-1. [DOI] [Google Scholar]
  18. Linderman R. J.; Graves D. M. Oxidation of Fluoroalkyl-Substituted Carbinols by the Dess-Martin Reagent. J. Org. Chem. 1989, 54, 661–668. 10.1021/jo00264a029. [DOI] [Google Scholar]
  19. Doi R.; Ohashi M.; Ogoshi S. Copper-Catalyzed Reaction of Trifluoromethylketones with Aldehydes via a Copper Difluoroenolate. Angew. Chem., Int. Ed. 2016, 55, 341–344. 10.1002/anie.201508266. [DOI] [PubMed] [Google Scholar]
  20. Zhang P.; Wolf C. Catalytic Enantioselective Difluoroalkylation of Aldehydes. Angew. Chem., Int. Ed. 2013, 52, 7869–7873. 10.1002/anie.201303551. [DOI] [PubMed] [Google Scholar]
  21. Decostanzi M.; Godemert J.; Oudeyer S.; Levacher V.; Campagne J.-M.; Leclerc E. Brook/Elimination/Aldol Reaction Sequence for the Direct One-Pot Preparation of Difluorinated Aldols from (Trifluoromethyl)trimethylsilane and Acylsilanes. Adv. Synth. & Catal. 2016, 358, 526–531. 10.1002/adsc.201500849. [DOI] [Google Scholar]
  22. Hare S. R.; Orman M.; Dewan F.; Dalchand E.; Buzard C.; Ahmed S.; Tolentino J. C.; Sethi U.; Terlizzi K.; Houferak C.; Stein A. M.; Stedronsky A.; Thamattoor D. M.; Tantillo D. J.; Merrer D. C. Experimental and Computational Mechanistic Investigation of Chlorocarbene Additions to Bridgehead Carbene–Anti-Bredt Systems: Noradamantylcarbene–Adamantene and Adamantylcarbene–Homoadamantene. J. Org. Chem. 2015, 80, 5049–5065. 10.1021/acs.joc.5b00456. [DOI] [PubMed] [Google Scholar]
  23. Han C.; Kim E. H.; Colby D. A. Cleavage of Carbon–Carbon Bonds through the Mild Release of Trifluoroacetate: Generation of α,α-Difluoroenolates for Aldol Reactions. J. Am. Chem. Soc. 2011, 133, 5802–5805. 10.1021/ja202213f. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

ao4c02105_si_001.pdf (9.6MB, pdf)

Articles from ACS Omega are provided here courtesy of American Chemical Society

RESOURCES